Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 23.06.2021.

Biotechnology
Google
Initial public offering
Organism
Medicine
Public company

Startups

@Forbes shared
On Jun 22, 2021
This biotech startup just raised $255 million to make its AI-designed drug a reality https://t.co/Cq3snDYhli https://t.co/NqsBNnOs4b
Open
This Biotech Startup Just Raised $255 Million To Make Its AI-Designed Drug A Reality

This Biotech Startup Just Raised $255 Million To Make Its AI-Designed Drug A Reality

Insilico Medicine aims to use its new cash infusion to take its first drug, a treatment for idiopathic pulmonary fibrosis, into clinical trials.

@ForbesTech shared
On Jun 18, 2021
23andMe's Anne Wojcicki becomes newest self-made billionaire after SPAC deal with Sir Richard Branson https://t.co/32Fey70wVB by @leah_rosenbaum
Open
23andMe’s Anne Wojcicki Becomes Newest Self-Made Billionaire After SPAC Deal With Sir Richard Branson

23andMe’s Anne Wojcicki Becomes Newest Self-Made Billionaire After SPAC Deal With Sir Richard Branson

Genetic testing company 23andMe went public today in an SPAC deal with U.K. tycoon Branson’s VG Acquisition Corp.

@BusinessInsider shared
On Jun 16, 2021
CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech https://t.co/5uuEz4kPHi
Open
CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech

CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech

CureVac's stock tanked after the announcement. The German biotech blamed variants in a press release.

@FierceBiotech shared
On Jun 22, 2021
Joining the C-suite are Johnston Erwin and Ovid Trifan, M.D., Ph.D. Erwin was a 36-year veteran at Lilly, recently as vice president of corporate business development for the Big Pharma's venture portfolio https://t.co/6QEUOaMh9A
Open
TRexBio has Jurassic day picking up ex-Lilly VP as CEO, snagging Big Pharma funding

TRexBio has Jurassic day picking up ex-Lilly VP as CEO, snagging Big Pharma funding

TRexBio is far from extinction as the discovery-stage biotech refuels with a new CEO and CMO and picks up Big Pharma backers.

@ScottKirsner shared
On Jun 22, 2021
Digital "medicine" company @Pear_Tx to go public in $1.6 billion #SPAC deal to treat diseases with software https://t.co/bNRbHgHf3b via @BostonGlobe
Open
Pear Therapeutics to go public in $1.6 billion SPAC deal to treat diseases with software

Pear Therapeutics to go public in $1.6 billion SPAC deal to treat diseases with software

Founded in 2013 in Boston and San Francisco, Pear has emerged as a leader in prescription digital therapeutics, a new class of medicines that use software to treat disease.

@ReutersBiz shared
On Jun 18, 2021
Thiel-backed psychedelics startup Atai valued at $3.19 bln in Nasdaq debut https://t.co/peAzAsWjk3 https://t.co/6olcnwx6OI
Open
Thiel-backed psychedelics startup Atai valued at $3.19 bln in Nasdaq debut

Thiel-backed psychedelics startup Atai valued at $3.19 bln in Nasdaq debut

Shares of Atai Life Sciences B.V. (ATAI.O), backed by billionaire investor Peter Thiel, surged 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a ...

@BentheFidler shared
On Jun 22, 2021
Blackstone to invest $250M in cell therapy #startup backed by Intellia, Cellex https://t.co/jsgJ6W2po9 by @NedPagliarulo $NTLA
Open
Blackstone to invest $250M in cell therapy startup backed by Intellia, Cellex

Blackstone to invest $250M in cell therapy startup backed by Intellia, Cellex

The new company aims to pair Intellia's CRISPR gene editing technology with a CAR-T cell therapy platform built by Cellex subsidiary GEMoaB. 

@MALifeSciences shared
On Jun 21, 2021
A #MondayMotivation read to start your week on @Ginkgo's Lily Fitzgerald, who began her career at the company with an #internship made possible by our Internship Challenge. Lily is now paying it forward, launching a fellowship program for students. 🔗 https://t.co/Ij1SvoNlXL https://t.co/W537m5qE3D
Open
Paying It Forward: Former Intern Building Own Talent Pipeline at Ginkgo Bioworks

Paying It Forward: Former Intern Building Own Talent Pipeline at Ginkgo Bioworks

Ginkgo Bioworks is a homegrown Boston-based biotechnology company. The “Organism Company” uses their engineered high throughput automation platform to design custom organisms to impact all ...

Read more: Startups
weekly 23.06.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy